Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial - Manns, M; Samuel, D; Gane, E J (The Lancet Infectious diseases, 2016)
et al.